Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMOZOLOMIDE Cause Blood glucose increased? 31 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Blood glucose increased have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.2% of all adverse event reports for TEMOZOLOMIDE.

31
Reports of Blood glucose increased with TEMOZOLOMIDE
0.2%
of all TEMOZOLOMIDE reports
5
Deaths
12
Hospitalizations

How Dangerous Is Blood glucose increased From TEMOZOLOMIDE?

Of the 31 reports, 5 (16.1%) resulted in death, 12 (38.7%) required hospitalization, and 2 (6.5%) were considered life-threatening.

Is Blood glucose increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 31 reports have been filed with the FAERS database.

What Other Side Effects Does TEMOZOLOMIDE Cause?

Disease progression (1,562) Death (1,403) Off label use (1,357) Product use in unapproved indication (1,353) Thrombocytopenia (1,300) Drug ineffective (1,131) Nausea (1,071) Neutropenia (809) Malignant neoplasm progression (779) Fatigue (766)

What Other Drugs Cause Blood glucose increased?

INSULIN LISPRO (31,969) INSULIN GLARGINE (19,234) DULAGLUTIDE (9,119) INSULIN HUMAN (8,704) INSULIN ASPART (4,743) METFORMIN (4,038) EXENATIDE (3,363) INSULIN DEGLUDEC (2,644) SEMAGLUTIDE (2,240) TIRZEPATIDE (2,240)

Which TEMOZOLOMIDE Alternatives Have Lower Blood glucose increased Risk?

TEMOZOLOMIDE vs TEMSIROLIMUS TEMOZOLOMIDE vs TENAMFETAMINE TEMOZOLOMIDE vs TENAPANOR TEMOZOLOMIDE vs TENECTEPLASE TEMOZOLOMIDE vs TENELIGLIPTIN

Related Pages

TEMOZOLOMIDE Full Profile All Blood glucose increased Reports All Drugs Causing Blood glucose increased TEMOZOLOMIDE Demographics